Our Team

    Meet Our Team

    Our highly complementary team brings together world-class expertise in science, technology, IT, management and business.

    Jelle ten Hoeve

    Jelle ten Hoeve

    Co-Founder & CEO

    15+ years in clinical & research IT, team management, and information security.

    Lorenzo Bombardelli, PhD

    Lorenzo Bombardelli, PhD

    Co-Founder & CSO

    Geneticist and entrepreneur with deep expertise in genetic engineering.

    Ashok Bangher

    Ashok Bangher

    Head of Quality

    Decades of experience in quality management at Lonza, GSK, and Eli Lilly.

    Andrei Kiselev, PhD

    Andrei Kiselev, PhD

    Plant Geneticist & Validation Lead

    Expert in plant genomics, data infrastructures, and statistical analysis.

    Andres Gimenez, PhD

    Andres Gimenez, PhD

    Bioinformatician

    Ph.D. in stem cell biology with extensive CRISPR genome editing experience.

    Szymon Szyszkowski

    Szymon Szyszkowski

    DevOps Engineer

    Computational biologist combining bioinformatics with DevOps expertise.

    Henrique Oliveira

    Henrique Oliveira

    DevOps Engineer

    Data scientist specializing in bioinformatics and automated testing.

    Jawahar Kopparam, PhD

    Jawahar Kopparam, PhD

    Business Developer

    Molecular life scientist with a decade of cancer research at NKI and Harvard.

    Santiago Gisler, PhD

    Santiago Gisler, PhD

    Scientific Communication & Strategy Consultant

    Freelance scientific communicator and strategic advisor with expertise in cancer research and molecular biology.

    Student internships

    We are open for student internships in bioinformatics, software engineering, and science communication. If you are interested in joining our team, please reach out with your CV and a short motivation.

    Contact us

    Start analysing your edits today

    Join leading research institutions and pharmaceutical companies that are already using TIDE for genome-editing success.

    No installation. No account required. Used in an FDA-approved cell therapy filing.